These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9690230)

  • 1. Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy.
    Cannella G; Paoletti E; Barocci S; Massarino F; Delfino R; Ravera G; Di Maio G; Nocera A; Patrone P; Rolla D
    Kidney Int; 1998 Aug; 54(2):618-26. PubMed ID: 9690230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
    Hernández D; Lacalzada J; Salido E; Linares J; Barragán A; Lorenzo V; Higueras L; Martín B; Rodríguez A; Laynez I; González-Posada JM; Torres A
    Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
    Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
    Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies.
    Sasaki M; Oki T; Iuchi A; Tabata T; Yamada H; Manabe K; Fukuda K; Abe M; Ito S
    J Hypertens; 1996 Dec; 14(12):1403-8. PubMed ID: 8986921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
    Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
    Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study.
    Cosenso-Martin LN; Vaz-de-Melo RO; Pereira LR; Cesarino CB; Yugar-Toledo JC; Cipullo JP; de Souza Pinhel MA; Souza DR; Vilela-Martin JF
    Eur J Med Res; 2015 Sep; 20(1):74. PubMed ID: 26336879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme gene polymorphism on the left-ventricular function and mass in patients with acromegaly.
    Erbas T; Alikasifoglu M; Aksöyek S; Unsal I; Gedik O; Tuncbilek E
    Cardiology; 1999; 92(4):226-31. PubMed ID: 10844381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the I/D angiotensin-converting enzyme genotype for detecting the risk of left ventricular hypertrophy in pharmacologically treated hypertensive men.
    López-Contreras J; Blanco-Vaca F; Borrás X; Carreras F; Pons-Lladó G; Gallego F; Solé MJ; Cirera S; Benet MT; Negredo E; Roca-Cusachs A
    J Hum Hypertens; 2000 May; 14(5):327-31. PubMed ID: 10822320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele.
    Prasad N; O'Kane KP; Johnstone HA; Wheeldon NM; McMahon AD; Webb DJ; MacDonald TM
    QJM; 1994 Nov; 87(11):659-62. PubMed ID: 7820539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects.
    Cannella G; Paoletti E; Delfino R; Peloso G; Rolla D; Molinari S
    Am J Kidney Dis; 1997 Nov; 30(5):659-64. PubMed ID: 9370181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between polymorphism of the angiotensin-converting enzyme gene and the response to angiotensin-converting enzyme inhibition in hypertensive patients.
    Yu H; Zhang Y; Liu G
    Hypertens Res; 2003 Nov; 26(11):881-6. PubMed ID: 14714579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.
    Perticone F; Ceravolo R; Cosco C; Trapasso M; Zingone A; Malatesta P; Perrotti N; Tramontano D; Mattioli PL
    J Am Coll Cardiol; 1997 Feb; 29(2):365-9. PubMed ID: 9014990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.
    Osono E; Kurihara S; Hayama N; Sakurai Y; Ohwada K; Onoda N; Takeuchi M; Tomizawa T; Komaba Y; Hashimoto K; Matsunobu S; Yoneshima H; Iino Y
    Am J Kidney Dis; 1998 Nov; 32(5):725-30. PubMed ID: 9820440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.